CollPlant Biotechnologies Ltd.

8.39+0.0500+0.60%Vol 6.45K1Y Perf -59.32%
Jun 24th, 2022 15:59 DELAYED
BID7.50 ASK10.48
Open8.55 Previous Close8.34
Pre-Market- After-Market8.07
 - -  -0.32 -3.81%
Target Price
21.50 
Analyst Rating
Strong Buy 1.00
Potential %
156.26 
Finscreener Ranking
★★★     48.85
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     44.72
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     57.17
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.57 
Earnings Rating
Strong Sell
Market Cap83.18M 
Earnings Date
18th Aug 2022
Alpha-0.04 Standard Deviation0.18
Beta2.08 

Today's Price Range

7.828.55

52W Range

7.5023.49

5 Year PE Ratio Range

-300.90-3.90

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.48%
1 Month
-10.55%
3 Months
-36.58%
6 Months
-36.54%
1 Year
-59.32%
3 Years
67.80%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLGN8.390.05000.60
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
15.80
16.30
0.06
0.08
-907.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
4.70
-1 137.40
-1 067.90
-624.30
1.16
RevenueValueIndustryS&P 500US Markets
1.21M
0.12
23.45
99.98
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.14-0.36-157.14
Q04 2021-0.26-0.30-15.38
Q03 2021-0.28-0.29-3.57
Q02 2021-0.10-0.30-200.00
Q01 20210.500.8876.00
Q04 2020-0.30-0.42-40.00
Q03 20200.920.07-92.39
Q02 2020-0.25-0.2020.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.07-133.33Negative
9/2022 QR-0.07-114.58Negative
12/2022 FY-0.38-120.11Negative
12/2023 FY3.19-54.94Negative
Next Report Date18th Aug 2022
Estimated EPS Next Report-0.08
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume6.45K
Shares Outstanding9.91K
Shares Float8.90M
Trades Count78
Dollar Volume52.63K
Avg. Volume15.70K
Avg. Weekly Volume9.72K
Avg. Monthly Volume12.59K
Avg. Quarterly Volume24.80K

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) stock closed at 8.39 per share at the end of the most recent trading day (a 0.6% change compared to the prior day closing price) with a volume of 6.45K shares and market capitalization of 83.18M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 38 people. CollPlant Biotechnologies Ltd. CEO is Yehiel Tal.

The one-year performance of CollPlant Biotechnologies Ltd. stock is -59.32%, while year-to-date (YTD) performance is -48.72%. CLGN stock has a five-year performance of %. Its 52-week range is between 7.5 and 23.49, which gives CLGN stock a 52-week price range ratio of 5.57%

CollPlant Biotechnologies Ltd. currently has a PE ratio of 70.10, a price-to-book (PB) ratio of 3.43, a price-to-sale (PS) ratio of 68.59, a price to cashflow ratio of 15.50, a PEG ratio of 2.32, a ROA of -26.90%, a ROC of -27.35% and a ROE of -30.21%. The company’s profit margin is 1.16%, its EBITDA margin is -1 067.90%, and its revenue ttm is $1.21 Million , which makes it $0.12 revenue per share.

Of the last four earnings reports from CollPlant Biotechnologies Ltd., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.08 for the next earnings report. CollPlant Biotechnologies Ltd.’s next earnings report date is 18th Aug 2022.

The consensus rating of Wall Street analysts for CollPlant Biotechnologies Ltd. is Strong Buy (1), with a target price of $21.5, which is +156.26% compared to the current price. The earnings rating for CollPlant Biotechnologies Ltd. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CollPlant Biotechnologies Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CollPlant Biotechnologies Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 25.40, ATR14 : 0.71, CCI20 : -77.81, Chaikin Money Flow : -0.01, MACD : -0.26, Money Flow Index : 30.04, ROC : -5.30, RSI : 43.35, STOCH (14,3) : 48.08, STOCH RSI : 0.91, UO : 58.84, Williams %R : -51.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CollPlant Biotechnologies Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd is a regenerative medicine company. It is focused on developing and commercializing tissue repair products, initially for 3D-bio printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants, and the company focuses on orthopedics and advanced wound care.

CEO: Yehiel Tal

Telephone: +972 732325600

Address: 4 Oppenheimer Street, Rehovot 7670104, , IL

Number of employees: 38

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

53%47%

Bearish Bullish

54%46%

TipRanks News for CLGN

Mon, 20 Jun 2022 09:01 GMT Analysts Are Bullish on These Healthcare Stocks: Collplant Holdings (CLGN)

- TipRanks. All rights reserved.

News

Stocktwits